403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Diabetes Could Cost The MENA Region $1.5 Trillion By 2050, New Study Indicates
(MENAFN- Mid-East Info) Research led by University of Birmingham Dubai with the World Health Organization highlights urgent need for prevention and stronger health systems
Dubai,November 2025: A new study produced by the University of Birmingham Dubai, in collaboration with the World Health Organization (WHO) Regional Office for the Eastern Mediterranean, warns that diabetes poses a significant economic threat to the Eastern Mediterranean (EMRO) region. The research, led by Dr. Khalifa Elmusharaf, Associate Professor and Director of the Public Health Programme at the University of Birmingham Dubai estimates that diabetes cost the region $ 639 billion in 2023, a figure projected to rise to $ 1.5 trillion by 2050 in the absence of urgent intervention. The study provides the most comprehensive estimate to date of both direct health costs and indirect productivity losses associated with diabetes across 22 countries. “This study sends a clear message to policymakers - diabetes is silently draining our economies,” said Dr. Khalifa Elmusharaf, Associate Professor and Director of the Public Health Programme at the University of Birmingham Dubai. “The majority of this burden - nearly 90% - comes from lost productivity, not hospital bills. If we continue to underinvest in prevention, the human and economic costs will become unmanageable.” Key Findings from the study indicate that:
Dubai,November 2025: A new study produced by the University of Birmingham Dubai, in collaboration with the World Health Organization (WHO) Regional Office for the Eastern Mediterranean, warns that diabetes poses a significant economic threat to the Eastern Mediterranean (EMRO) region. The research, led by Dr. Khalifa Elmusharaf, Associate Professor and Director of the Public Health Programme at the University of Birmingham Dubai estimates that diabetes cost the region $ 639 billion in 2023, a figure projected to rise to $ 1.5 trillion by 2050 in the absence of urgent intervention. The study provides the most comprehensive estimate to date of both direct health costs and indirect productivity losses associated with diabetes across 22 countries. “This study sends a clear message to policymakers - diabetes is silently draining our economies,” said Dr. Khalifa Elmusharaf, Associate Professor and Director of the Public Health Programme at the University of Birmingham Dubai. “The majority of this burden - nearly 90% - comes from lost productivity, not hospital bills. If we continue to underinvest in prevention, the human and economic costs will become unmanageable.” Key Findings from the study indicate that:
-
Over 74 million people in the region were living with diabetes in 2023
The disease caused over 830,000 deaths last year
89% of the total economic burden is due to indirect costs (loss of productivity and early deaths)
The annual economic burden equals 5.9% of regional GDP
By 2050, diabetes cases will double to 150 million, with 2 million deaths per year expected
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment